ESRX Express Scripts Holding Company (delisted)

   By Aisha Al-Muslim 
 

Express Scripts Holding Co. (ESRX) on Wednesday reported a profit for the third quarter of $1.07 billion, or $1.89 a share, up from $841.7 million, or $1.46 a share, a year earlier.

Adjusted earnings were $2.43 a share, in line with what analysts polled by Refinitiv were expecting.

Revenues for the pharmacy-benefits manager rose 3.6% to $25.56 billion, ahead of the consensus forecast of $25.04 billion.

The company now expects its 2019 retention rate for the 2018 selling season to exceed 98%, its all-time high, compared with its previous outlook of between 97.5% and 98.5%. The company also expects to grow its core business adjusted claims by 2% to 3% in 2019.

The pending acquistion of Express Scripts by Cigna Corp. (CI) is expected to be completed by Dec. 31, after the proposed del was cleared by the U.S. Department of Justice in September.

Write to Aisha Al-Muslim at aisha.al-muslim@wsj.com

(END) Dow Jones Newswires

October 31, 2018 16:55 ET (20:55 GMT)

Express Scripts Holding Company (delisted) (NASDAQ:ESRX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Express Scripts Holding Company (delisted) (NASDAQ:ESRX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024